Last updated on April 23, 2014 at 21:24 EDT

Health News Archive - June 11, 2006

By Ransdell Pierson and Bill Berkrot NEW YORK (Reuters) - An experimental drug by Eli Lilly and Co. showed promise in reducing vision loss caused by the effects of diabetes on the retina, according to combined data from a pair of late-stage clinical trials presented on Sunday.